Virus neutralizing assays (VNAs) are the gold standard for screening serum for neutralizing antibodies in vitro. These are being used, in many cases, to treat early coronavirus disease 2019 (COVID-19) ...
A unique and rapid SARS-CoV-2 surrogate virus neutralisation test (sVNT) may be the much needed boost to current COVID-19 investigations to determine infection rate, herd immunity, predicted humoral ...
A recent study by US researchers, currently available on the medRxiv* preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in ...
Mutations of virus and illnesses caused by new variants are still to be expected even in a SARS-CoV-2 situation that has now become endemic. Although the population has developed specific immune ...
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern pose a challenge to the effectiveness of current vaccines. A vaccine that could prevent infection caused by ...
A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of Medicine, The Chinese University of Hong Kong (CU Medicine) has revealed that ...
SARS-CoV-2 vaccine efficacy testing is now facing increasing challenges in the face of an ongoing pandemic with the emergence of new variants and waning vaccine immunity. Evidence supports the ...
Evaluation of a 'plaque reduction neutralization test'. Using blood samples from COVID-19 patients, this test detects the antibodies which neutralize the SARS-CoV-2 virus, i.e. stop the virus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results